Skip to content
Cullinan Oncology Inc icon

Cullinan Oncology Inc

CGEMStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$15.64

Today

+0.8%

YTD

+50.1%

About

Cullinan Oncology, Inc. is a biopharmaceutical company focused on the discovery and advancement of life-saving oncology treatments, operating from Massachusetts. Operating in the dynamic and complex healthcare sector, this company is intricately involved in the field of oncology. Its services are centred around developing and commercialising novel, targeted cancer treatments, harnessing advanced technology and science to create solutions that can provide better outcomes for patients. Cullinan Oncology is not part of any larger organisation and has no subsidiaries. Monitor the CGEM share price by adding it to your eToro watchlist.

Price chart
Closing price history for CGEM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-4.57
P/S (TTM)0.00
P/B (TTM)3.11
Market cap$1.00B
Cap tierSmall-cap
Industry avg P/E-7.37

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-50.30%
ROA-46.30%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$3.39
Free cash flow$-145.30M
Total debt$2.07M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.25
Employees109
Next earnings14 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.